Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004). Due to its chronic and relapsing nature, atopic dermatitis presents a global public health concern, with reported lifetime prevalence ranging between 10%–20% in children and 1%–3% in adults (Larsen and Hanifin, 2002). In general, the prevalence of atopic dermatitis is increasing worldwide, with high prevalence in western and developed nations compared with other parts of the world.

1. EpiCast Report: Atopic Dermatitis-Epidemiology Forecast to 2022
Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions
and rashes. Though the condition affects people of all ages, it is primarily common among infants and children
(Bowcock and Cookson, 2004). Due to its chronic and relapsing nature, atopic dermatitis presents a global
public health concern, with reported lifetime prevalence ranging between 10%–20% in children and
1%–3% in adults (Larsen and Hanifin, 2002). In general, the prevalence of atopic dermatitis is
increasing worldwide, with high prevalence in western and developed nations compared with other parts of the
world. However, recent trends demonstrate a gradual rise in prevalence in developing countries and plateauing
prevalence in developed countries (Asher et al., 2006). Although atopic dermatitis is not life-threatening, it has
a huge impact on economic burden and quality of life of individuals (Carroll et al., 2005).
GlobalData’s epidemiological analysis forecasts that prevalent cases of atopic dermatitis in the 9MM
(US, France, Germany, Italy, Spain, UK, Japan, China, and India) will increase from 132.28 million in 2012 to
132.71 million cases in 2022 at an annual growth rate (AGR) of 0.10%. In 2012, China and India combined
contributed 83.04 million cases, comprising more than 60% of the total prevalent cases in the 9MM.
GlobalData’s epidemiological forecast projects a substantial increase in the lifetime prevalent cases of
atopic dermatitis in the 9MM over the forecast period (2012–2022). As GlobalData epidemiologists
used steady prevalence proportions of atopic dermatitis over the forecast period, the growth in prevalent cases
in each market can be attributed to the change in population demographics in the respective markets,
especially in the younger age groups as they comprise the highest proportion of the prevalent cases.
The forecast underscores the considerable psychosocial and economic burden inflicted by atopic dermatitis
particularly among children. Governments in the respective markets should develop strategies to tackle the
growing problem and direct appropriate interventions towards reducing various triggers inducing atopic
dermatitis especially among young children (Williams et al., 2012).
Scope
The Atopic Dermatitis EpiCast Report and EpiCast Model provide an overview of the risk factors and global
trends of atopic dermatitis in the 9MM. It includes a 10-year epidemiology forecast of atopic dermatitis
prevalent cases segmented by age (in five-year increments beginning at age 0 and ending at ages 85 years and
older), sex, and severity (mild, moderate, and severe) in the 9MM.
Reasons To Buy
Develop business strategies by understanding the trends shaping and driving the global atopic dermatitis
market. Quantify patient populations in the global atopic dermatitis market to improve product design, pricing,
and launch plans. Organize sales and marketing efforts by identifying the age groups and sex that present the
best opportunities for atopic dermatitis therapeutics in each of the markets covered. Identify the percentage of
atopic dermatitis prevalent cases that are mild, moderate, and severe.
table Of Contents
EpiCast Report: Atopic Dermatitis-Epidemiology Forecast to 2022

2. 1table Of Contents1
1.1list Of Tables2
1.2list Of Figures2
2executive Summary3
3introduction5
3.1catalyst5
3.2related Reports5
3.3upcoming Reports6
4epidemiology6
4.1disease Background6
4.2risk Factors And Comorbidities6
4.2.1children Ages = 10 Years Are Three Times More Likely To Develop Atopic Dermatitis7
4.2.2family History Of Atopic Disease Increases The Risk Of Atopic Dermatitis Six-fold8
4.2.3allergens Are Associated With A Six-fold Risk Of Atopic Dermatitis9
4.2.4breastfeeding For More Than Four Months Protects Children From Atopic Dermatitis10
4.2.5asthma, Allergic Rhinitis And Allergic Conjunctivitis Commonly Occur With Atopic Dermatitis11
4.2.6atopic Dermatitis Patients Are Up To Three Times More Likely To Have Psychiatric Disorders12
4.3global Trends12
4.3.1us13
4.3.25eu13
4.3.3japan17
4.3.4china17
4.3.5india18
4.4forecast Methodology18
4.4.1sources Used21
4.4.2sources Not Used27
4.5forecast Assumptions And Methods28
4.5.1us28
4.5.2france28
4.5.3germany30
4.5.4italy31
4.5.5spain31
4.5.6uk32
4.5.7japan32
4.5.8china32
4.5.9india33
4.6epidemiology Forecast Of Atopic Dermatitis (2001–2022)34
EpiCast Report: Atopic Dermatitis-Epidemiology Forecast to 2022

3. 4.6.1lifetime Prevalent Cases Of Atopic Dermatitis34
4.6.2age-specific Prevalent Cases Of Lifetime Atopic Dermatitis35
4.6.3sex-specific Prevalent Cases Of Lifetime Atopic Dermatitis37
4.6.4age-standardized Lifetime Prevalence Of Atopic Dermatitis39
4.6.5prevalent Cases Of Atopic Dermatitis By Severity40
4.7discussion41
4.7.1conclusions On Epidemiological Trends41
4.7.2limitations Of The Analysis43
4.7.3strengths Of The Analysis44
5appendix44
5.1bibliography44
5.2about The Authors52
5.2.1epidemiologist52
5.2.2reviewers52
5.2.3global Director Of Epidemiology And Clinical Trials Analysis53
5.2.4global Head Of Healthcare53
5.3about Globaldata54
5.4about Epicast54
5.5contact Us54
5.6disclaimer55
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
EpiCast Report: Atopic Dermatitis-Epidemiology Forecast to 2022